Force TV is a channel Family Offices to find insights from experts, deep dives into important topics, overviews of great companies looking for partners, and opportunities to spread the word about their philanthropic endeavors. There’s always new content on the way, so bookmark the page and come back every week.
Force Insights
Peter Boockvar, CNBC Contributor and Chief Investment Officer at Bleakley Financial Group, joined Force Family Office for a discussion on investing during unsettled economic times.
Peter Boockvar, CNBC Contributor and Chief Investment Officer at Bleakley Financial Group, joined Force Family Office for a discussion on investing during unsettled economic times.
Peter Boockvar, CNBC Contributor and Chief Investment Officer at Bleakley Financial Group, joined Force Family Office for a discussion on investing during unsettled economic times.
Peter Boockvar, CNBC Contributor and Chief Investment Officer at Bleakley Financial Group, joined Force Family Office for a discussion on investing during unsettled economic times.
Peter Boockvar, CNBC Contributor and Chief Investment Officer at Bleakley Financial Group, joined Force Family Office for a discussion on investing during unsettled economic times.
Force For Knowledge
Peter Boockvar and Jean Altier Bohm from Goldman Sachs join Force Family Office CEO, Steven Saltzstein for a wide ranging discussion on investment strategies for these turbulent times.
When congress passed the 21st Century Cures Act in 2016, it quickly became known as the Cancer Moonshot, and had the goal of making a decade’s worth of progress in just five years in the prevention, diagnosis, and treatment of cancer, a disease that takes 1,800 lives per day.
FORCE brought together a panel of influential voices to give an update on the Moonshot:
Greg Simon: Executive Director for both the Biden Cancer Initiative, the White House Cancer Moonshot Task Force, and co-author of the soon-to-be-released book “The Moonshot and Beyond”
Brian Frenzel: CEO of Tosk a biopharmaceutical company that’s developing medications to reduce the side effects of cancer
Dr. Stacy Blain: Chief Science Officer and co-founder of Concarlo, a biopharmaceutical company developing solutions for drug-resistant breast cancer
Lannia Stenz: Executive Director of Gilda’s Club, Madison, a non-profit that provides free emotional support and educational resources to anyone who’s been affected by cancer.
FORCE Family Office and Roth Capital Partners hosted a symposium on electric vehicle infrastructure including leading tech companies Ideanomics, Luokung, Blink Charging, Nuvve, and Beam Global.
FORCE Family Office and Roth Capital Partners Co-hosted a symposium on the Future of EVs with leading manufacturers including Canoo, Lordstown Motors, Lion Electric, Electra Meccanica, and XL Fleet.
Leaders from Ideanomics, Charge Enterprises, Vivopower, and American Battery Technology Corp discuss the how the electrification of mobility will change our transportation ecosystem forever.
An overview of the technology behind the biggest change to the internet since the introduction of broadband with leaders from nVIDIA, Cloudalize, and EscherCloud.
Force Webinars
Join Kendra Barkoff Lamy, former Press Secretary to Vice President Joe Biden, and Dr. Tom Pey, CEO of Waymap, as they discuss how advanced, precision wayfinding can make cities, universities, transportation systems, even office buildings work better for everyone.
Waymap’s innovative system and approach was developed to help visually impaired people navigate cities, but has applications for everyone. It has been tried and tested in cities across North America and Europe and is already making inclusivity and accessibility a reality in Washington D.C.
Boom Supersonic is revolutionizing commercial flight by bringing supersonic flight back to the skies with Overture.
In this webinar with Boom CEO, Blake Scholl we learned more about this historic commercial airliner which is designed and committed to industry-leading standards of speed, safety, and sustainability.
Why Alkaline88 is partnering with Shaquille O'Neal to tell its story of innovation and sustainability
James Joyce, co-founder and CEO of Sigyn Therapeutics shares the latest data on their new medical device and how it can help save millions of lives every year by transforming the treatment of people with sepsis.
NanoTomer is poised to launch what is arguably the broadest drug delivery platform ever developed. Their patented Anti-body Drug Conjugate (ADC) targets High Endothelial Venules (HEVs) that exist only in tumor draining lymph nodes, metastatic lesions, and cancerous tumors. This hyper precision targeting means just 1/7,000 of a traditional dose can have a greater impact on multiple cancers and immune mediated diseases like Type 1 Diabetes, Multiple Sclerosis, and more, with minimal side effects.
In this webinar the inventor of this technology, Dr. Reza Abdi and NanoTomer CEO, Jeff Bell present their pre-clinical data in preparation for an IND filing with the FDA.
InflammX Therapeutics has developed Xiflam, a once daily pill that’s proven effective in regulating out of control inflammation in both the eyes and liver. In a recent test in small animals that were born with diabetes and had significant impairment of visual function at 4 weeks, Xiflam reduced inflammation, resolved the microvascular pathology, and significantly restored visual function.
In this webinar, InflammX CEO, Dr. Brian Levy share details of this very promising development in the treatment of two of the most common and devastating side effects of diabetes.
AOBiome Therapeutics has developed a natural topical biologic spray that in Phase 2 clinical trials proved to be an effective treatment for atopic dermatitis, an inflammatory skin condition with a market value of nearly $4B in the U.S. alone.
It is as a safe as a water, making it an excellent choice for a first line therapy for mild to moderate itch and inflammation from dermatitis, acne, rosacea, and psoriasis.
In this webinar AOBiome President & CEO, Todd Krueger, discusses the company's science, their upcoming Phase 3 clinical trial and the path to commercialization.
Cybercriminals now regularly target the personal digital lives of individuals and families with wealth, access, status, and reputation because it’s easier than hacking well-defensed companies.
In this webinar with BlackCloak Founder & CEO, Dr. Chris Pierson and DataTribe co-founder, Michael Janke, you'll learn about cybersecurity strategies for Family Offices and high-net-worth individuals.
Heritage Distilling Co., a leading craft distiller of innovative premium brands, is joining forces with Better World Acquisition Corp. (NASDAQ: BWAC) to accelerate growth for the company's award-winning family of premium whiskies, gin, vodkas, rums, and ready-to-drink cocktails.
Join our webinar with Heritage CEO, Justin Stiefel, and BWAC CEO, Rosemary Ripley as they discuss how the team's combined experience with Heineken, Remy Martin, Kraft, Starbucks, Brown Foreman and others, along with a differentiated, capital light growth platform, will help the company become a leader in the $23B craft spirits industry.
Force For Good
Leaders from Concarlo Therapeutics and Her Health EQ discuss gender disparities in cancer care and potential solutions to this intractable problem.
The Shannon Elizabeth Foundation and the Bart Chilton Fellowship discuss how their programs are helping to create leaders for a changing world.
FORCE welcomed Danielle Butin, founder of the AFYA Foundation, and Jonathan Greenwald from the Greenwald Family Impact Foundation to talk about how donors can multiply their philanthropic impact by giving more than money to the organizations they care about.
Olymipic Gold Medal Soccer star Brandi Chastain joins Equipped for Life, the Sports Philanthropy Network, and Tapin Mobile Solutions to talk about the impact youth sports makes on a community and the next generation of leaders.